Ultra-short antimicrobial Peptoids show propensity for membrane activity against multi-drug resistant Mycobacterium tuberculosis
These are rare but can include mild discomfort at the injection site
P2Y 2 receptor agonists, denufosol (OLIYNYK et al., 2010), were promising for their ability to activate alternative chloride secretion pathways, but both of these agonists have not been pursued further due to not meeting primary study goals of improving FEV 1 (Ratjen et al., 2012) and having a narrow effective concentration range, respectively (OLIYNYK et al., 2010)
Inclusion and ethics statement The study presented here, has been approved and annually reviewed by the ethics board of the Ministry of Health of the Democratic Republic of the Congo (DRC) and the IRB board of the Oregon Health and Sciences University
Acta Pharmacol Sin 41:471482
Packaging of ZQ-II Anti-Aging GHK-Cu Serum (3ml x 3 vials)